Showing results (1161-1170 of 1,426) with videos related to
Sort By:
Pageof 143
Scientific Reports|November 29, 2017
Towards the cell-instructive bactericidal substrate: exploring the combination of nanotopographical features and integrin selective synthetic ligandsRoberta Fraioli, Penelope M Tsimbouri, Leanne E Fisher, et al.Plos One|January 3, 2018
Tetrahydrocarbazoles are a novel class of potent P-type ATPase inhibitors with antifungal activityMaike Bublitz, Lasse Kjellerup, Karen O'Hanlon Cohrt, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 27, 2019
Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction-An iSTEMI substudyMartin Sejr-Hansen, Jelmer Westra, Troels Thim, et al.Advanced Healthcare Materials|February 19, 2016
Analysis of Osteoclastogenesis/Osteoblastogenesis on Nanotopographical Titania SurfacesRobert K Silverwood, Paul G Fairhurst, Terje Sjöström, et al.Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|April 18, 2018
Control of cell behaviour through nanovibrational stimulation: nanokickingShaun N Robertson, Paul Campsie, Peter G Childs, et al.Bioanalysis|August 4, 2025
Navigating IVDR challenges for pharmacokinetic, anti-drug antibodies, and biomarker assays in early clinical research: a recommendation from the European Bioanalysis ForumPhilip Timmerman, Matthew Barfield, Jon G Bartlet, et al.American Heart Journal|December 3, 2014
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?Kurt Huber, Eric R Bates, Marco Valgimigli, et al.Plos One|February 7, 2018
Mid-to-long term mortality following surgical versus percutaneous coronary revascularization stratified according to stent subtype: An analysis of 6,682 patients with multivessel diseaseShahzad G Raja, Charles Ilsley, Fabio De Robertis, et al.European Journal of Endocrinology|May 18, 2026
Navepegritide Combined with Lonapegsomatropin for the Treatment of Children with Achondroplasia: 52-Week Results from the Phase 2 COACH TrialCiara M McDonnell, Melita Irving, Line Aagaard Nolting, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 11, 2019
Abnormal Amyloid Load in Mild Cognitive Impairment: The Effect of Reducing the PiB-PET ThresholdRola Ismail, Peter Parbo, Kim V Hansen, et al.Pageof 143